MTMR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.869790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.569600E-01
Normal-vs-Stage2
1.023950E-01
Normal-vs-Stage3
4.643600E-02
Normal-vs-Stage4
2.124800E-01
Stage1-vs-Stage2
1.789840E-02
Stage1-vs-Stage3
2.659900E-02
Stage1-vs-Stage4
1.626360E-01
Stage2-vs-Stage3
2.701000E-01
Stage2-vs-Stage4
8.467600E-01
Stage3-vs-Stage4
1.772640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.854400E-01
Normal-vs-AfricanAmerican
5.518000E-01
Normal-vs-Asian
1.478220E-01
Caucasian-vs-AfricanAmerican
4.021000E-01
Caucasian-vs-Asian
4.924200E-01
AfricanAmerican-vs-Asian
2.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.840220E-01
Normal-vs-Female
2.021200E-01
Male-vs-Female
3.039400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.217800E-01
Normal-vs-Age(41-60Yrs)
2.732600E-01
Normal-vs-Age(61-80Yrs)
1.817220E-01
Normal-vs-Age(81-100Yrs)
2.566100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.963000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.614600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.216650E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.790470E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.678000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.385600E-02
Normal-vs-Daily Drinker
8.401500E-02
Normal-vs-Weekly Drinker
1.548230E-01
Normal-vs-Occasional Drinker
2.877400E-01
Normal-vs-Social Drinker
4.596400E-01
Non Drinker-vs-Daily Drinker
7.984200E-01
Non Drinker-vs-Weekly Drinker
3.260400E-01
Non Drinker-vs-Occasional Drinker
6.096500E-02
Non Drinker-vs-Social Drinker
2.606200E-02
Daily Drinker-vs-Weekly Drinker
5.142600E-01
Daily Drinker-vs-Occasional Drinker
1.550550E-01
Daily Drinker-vs-Social Drinker
8.032000E-02
Weekly Drinker-vs-Occasional Drinker
4.944800E-01
Weekly Drinker-vs-Social Drinker
2.937200E-01
Occasional Drinker-vs-Social Drinker
6.492000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.977200E-01
Normal-vs-Grade 2
8.793800E-02
Normal-vs-Grade 3
5.786400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.723800E-01
Grade 1-vs-Grade 3
5.838200E-01
Grade 1-vs-Grade 4
2.977200E-01
Grade 2-vs-Grade 3
7.791400E-01
Grade 2-vs-Grade 4
8.793800E-02
Grade 3-vs-Grade 4
5.786400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.865900E-02
Normal-vs-NonDiabetic
1.978170E-01
Diabetic-vs-NonDiabetic
3.348200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.689800E-01
Normal-vs-NoPancreatitis
1.506420E-01
Pancreatitis-vs-NoPancreatitis
4.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.617000E-01
Normal-vs-N1
1.080800E-01
N0-vs-N1
6.431800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.021420E-01
Normal-vs-TP53-NonMutant
5.198800E-01
TP53-Mutant-vs-TP53-NonMutant
6.257800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
